Skip to main content
padlock icon - secure page this page is secure

Real‐world use—Isavuconazole at a large academic medical center

Buy Article:

$52.00 + tax (Refund Policy)

Isavuconazole use in the real‐world setting has not been extensively described. Subgroups of patients with particular prognostic significance, such as previous triazole prophylaxis or treatment and the important subgroup treated empirically for invasive fungal infection, have beforehand been excluded from trials.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Aspergillus; antifungals; isavuconazole; mucormycosis; triazoles

Document Type: Research Article

Publication date: June 1, 2019

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more